Multiple GPCR conformations and signalling pathways: implications for antagonist affinity estimates
2007
Understanding Antagonist Affinity in GPCRs
publication
Evidence: moderate
Author Information
Author(s): Jillian G. Baker, Stephen J. Hill
Primary Institution: Institute of Cell Signalling, Medical School, Nottingham, UK
Hypothesis
Can antagonist affinity measurements vary depending on the agonist and experimental conditions?
Conclusion
Antagonist affinities can differ based on the agonist used and the specific receptor conformation.
Supporting Evidence
- Antagonist affinities can vary depending on the agonist used.
- Different GPCR conformations can lead to different pharmacological profiles.
- Allosteric ligands can influence antagonist binding.
- Antagonist effects can differ based on the specific signalling pathway activated.
Takeaway
Sometimes, the way a medicine works can change depending on what other medicines are around it or how the body is using it.
Methodology
The study discusses various mechanisms affecting antagonist affinity in GPCRs, including allosterism and different G protein coupling.
Limitations
The study primarily discusses theoretical implications without presenting new experimental data.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website